Patients wary of medical negligence and unnecessary tests by doctors need not be nervous at the time of hospitalisation anymore. The government is in the process of framing clinical guidelines for the treatment of widely-prent diseases. Doctors would have to follow these guidelines.
Patients wary of medical negligence and unnecessary tests by doctors need not be nervous at the time of hospitalisation anymore. The government is in the process of framing clinical guidelines for the treatment of widely-prent diseases. Doctors would have to follow these guidelines.
[This article was published in the May 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
India News
[This article was published in the April 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
The Indian healthcare sector is on a high-growth trajectory propelled by unparalleled domestic growth, increasing public awareness and growing global interest in India�s delivery capabilities.
Siemens Healthcare has announced its first molecular imaging biomarker production facility in Chennai, India. The new facility will enable the healthcare providers in and around Chennai to access the positron emission tomography-computed tomography (PET-CT) technology to diagnose patients with life-threatening diseases, such as cancer and cardiac and neurological ailments.
Transasia Bio-Medicals Ltd, leader in the Clinical Diagnostics Segment across the Indian healthcare sector, which aids in diagnosing life threatening diseases faced by the humankind such as, AIDS, Tuberculosis, Cancer and Diabetes etc. has been awarded ISO 13485 (Quality Management Systems for Medical Devices) by UL India, a certifying body to foster quality assurance and improvement.
The World Health Organisation (WHO) has finalised and deployed a regional disease alert system that will soon be adopted by the UAE, said a WHO expert recently.
Venture capitalists pumped a record USD 9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of making discoveries they can sell to larger drugmakers.
Union Health Minister, Dr. Anbumani Ramadoss, currently on an official visit to France, discussed cooperation in certain fields such as Medical Research, Biotechnology, Development of vaccine, Promotion of Indian Systems of medicines and cooperation between ICMR and INSERM of France
India and other developing countries are set to lobby hard for funding mechanisms to develop medicines,
mostly aimed at neglected diseases such as tuberculosis and malaria, at a forum set up by the World Health Organization or WHO. Developed countries have long maintained that patents are sufficient incentive for innovation.
The firms plan on using advanced technologies to find cheaper ways to discover blockages in the heart, tumours
Drug makers can hope for tax sops for research activities to continue till 2015. Thus, consumers can hope for some reduction in the prices of drugs across the board and particularly in the case of cancer and HIV/AIDs drugs soon.
